Clin2
NCT07833072Possibly a fitNot yet recruiting

Safety of a single-dose nasal spray in healthy adults

Healthy Volunteers

This study tests a new nasal spray (DMI019) in healthy volunteers to see if it is safe and how the body handles it. Participants will receive a single dose and be monitored for a few weeks.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
48 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are between 18 and 45 years old.
  • You are in good general health with no major medical conditions.
  • You have no significant nasal issues (like chronic stuffiness, nosebleeds, or nasal surgery).
  • You are not taking any medications (prescription, over-the-counter, or herbal) in the 2 weeks before the study.
  • You can avoid smoking, alcohol, and certain foods (like grapefruit) during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07163182Recruiting· Phase 1
Safety study of nasal CHF6467 in healthy volunteers

This study tests a new medicine called CHF6467 given as a nasal spray. It looks at how safe the medicine is, how it is absorbed and removed from the body, and what side effects it might cause. Healthy volunteers aged 18 to 55 can take part.

Sofia
NCT07804628Not yet recruiting· Phase 1
Safety study of an inhaled dry powder in healthy adults

This study tests a new inhaled dry powder medicine (called ICF001) in healthy volunteers to see how safe it is and what side effects it might cause. It is a first-in-human study, so participants will help researchers understand the drug's effects and how it moves through the body.

Brisbane, Queensland
NCT07474545Recruiting· Phase 1
Safety study of KL0011034 injection in healthy volunteers

This trial tests a new injection called KL0011034 to see if it is safe and how the body processes it. Healthy volunteers aged 18–45 who meet specific health and lifestyle criteria can join.

Changsha, Hunan
NCT07503015Not yet recruiting· Phase 1
Testing HS-20152 in healthy volunteers

This study tests a new medicine called HS-20152 in healthy people to see if it is safe and how the body handles it. It is an early-phase trial, so it helps find the right dose and check for side effects.

Qingdao, Shandong
NCT07852208Not yet recruiting· Phase 1
Safety of a nasal spray in healthy adults

This trial tests a new nasal spray (called LMN-1001) in healthy adults to see if it is safe and how the body handles it. It is an early-phase study, so the main goal is not to treat a disease but to check for safety and side effects.

Randwick, New South Wales
NCT06857890Recruiting· Phase 1
Safety study of Grammidin throat spray in healthy volunteers

This trial tests a new throat spray called Grammidin With Anesthetic to see if it is safe and how the body processes it. Healthy volunteers take the spray and are monitored for side effects and drug levels in the blood.

Moscow

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.